CTSO and breast cancer: In a separate study, it was also shown that the variant GG genotype for the CTSO rs10030044 SNP was an independent factor indicating a poor prognosis in ER+ breast cancer patients receiving adjuvant tamoxifen therapy [21], which suggested the involvement of this genetic locus in tamoxifen response.